Oxaprozin
- Product NDC
- 60760-203
- 11-digit product format
- 607600203
- Labeler code
- 60760
- Product ID
- 60760-203_7acac128-27f4-0a85-e053-2991aa0a1713
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxaprozin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA075845
- Marketing category
- ANDA
- Marketing start
- 2018-05-08
- Marketing end
- 0000-00-00
- Substance
- OXAPROZIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60760-203 | OXAPROZIN TABLET [ST. MARY'S MEDICAL PARK PHARMACY] | 2 | Legacy NDC | 20181117_6bb78fd2-5d6f-1b41-e053-2991aa0af497.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-203-14 | 60760020314 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-203-14) | 14 tablet | 2018-05-08 | 0000-00-00 | No | No | Current |